In our study, we have found that MMP-2 genes were downregulated in diabetic cardiopathy I, proteoglycans in cancer, estrogen signaling, fluid shear stress and atherosclerosis, relaxing signaling, bladder cancer, and GnRH signaling pathways (Supplementary File S1). Here, MMP2 is linked to urinary bladder cancer.